logo
Select company
Select metric
-26.82%Return on Assets
VS
Market
21
Sector
57
Industry
75
History
83
$ 8.24Close
$ 3.99 - $ 9.88 52-Week Range
Ticker Information

Ticker

FENC

Company Name

FENNEC PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

FENNEC PHARMACEUTICALS INC - Return on Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

FENC - ROA Historical data
DateTotal AssetsNet Income Common StockReturn on Assets
6/30/2025$ 44.88M$ -12.04M-26.82%
3/31/2025$ 46.4M$ -14.44M-31.11%
12/31/2024$ 44.95M$ -436K-0.97%
9/30/2024$ 58.92M$ -227K-0.39%
6/30/2024$ 63.16M$ 3.64M5.76%
3/31/2024$ 69.19M$ 3.75M5.42%
12/31/2023$ 26.86M$ -16.05M-59.73%
9/30/2023$ 19.03M$ -20.22M-106.26%
6/30/2023$ 19.44M$ -26.44M-136.04%
3/31/2023$ 21.82M$ -26.07M-119.47%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • FENNEC PHARMACEUTICALS INC's latest trailing twelve months (TTM) ROA stands at -54.24%.
  • Over the past 5 years, FENNEC PHARMACEUTICALS INC's average ROA has been -60.44%.
  • The median ROA for FENNEC PHARMACEUTICALS INC during this period was -63.37%
  • FENNEC PHARMACEUTICALS INC reached its highest ROA over the past 5 years at 5.76%.
  • The lowest ROA recorded by FENNEC PHARMACEUTICALS INC in the same timeframe -136.04%

FENNEC PHARMACEUTICALS INC's ROA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROA Benchmarks
CompanyROA
CCCC : C4 THERAPEUTICS INC -37.63%VYGR : VOYAGER THERAPEUTICS INC -33.51%EDIT : EDITAS MEDICINE INC -112.48%OABI : OMNIAB INC -21.48%FHTX : FOGHORN THERAPEUTICS INC -33.33%SCPH : SCPHARMACEUTICALS INC -114.28%STXS : STEREOTAXIS INC -59.84%LCTX : LINEAGE CELL THERAPEUTICS INC -45.06%MGX : METAGENOMI INC -32%MXCT : MAXCYTE INC -20.37%

Definition of Return on Assets

[Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
Net Inc. Cmn. / Assets
(=) ROA
ROA for FENNEC PHARMACEUTICALS INC is calculated as follows: Net Inc. Cmn. [ $ -18.48M ] / Assets [ $ 34.07M ]
(=) ROA [ -54.24% ]

FENC - Return on Assets, Last 5 years

-136.04%

Minimum

Jun 30, 2023

5.76%

Maximum

Jun 30, 2024

-60.44%

Average

-63.37%

Median

ROA Benchmark Analysis

The chart above depicts the distribution of ROA for companies in the Total Stock Market. The average ROA of the companies is 0.1% with a standard deviation of 10.63%.
The following table provides additional summary stats:
ROA in the Market:
filtered constituents3.45K
min-33.42%
max33.98%
average0.1%
median1.53%
std10.63%